MG2 Checkweigher Operates at High Speeds - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

MG2 Checkweigher Operates at High Speeds


The MG2 Selekta is a high-speed checkweigher and sorting machine for tablet production. Selekta offers flexibility in the product shapes and sizes it can handle.  Depending on the product, Selekta can check up to 500,000 units per hour and is designed for integration with continuous-processing tableting equipment. Selekta incorporates MG2's Multi-NETT weight-control system that can monitor and control net weight in low-dose applications (5–25mg). The machine selects conforming and nonconforming units through a fail-safe system employing a set of sensors located at critical points throughout the testing process. The unit can be directly connected downstream from primary production equipment, upstream of blister lines, or used as a standalone unit with automatic or manual load. Two special versions of Selekta are available for integration into packaging lines where tablets are placed into bottles: Selekta/CW performs product counting as well as weighing, and Selekta/C's sole function is counting.

Source: MG2

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here